TransMedics to Participate in the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

TransMedics Group, Inc. (Nasdaq: TMDX) announced its management team's presentation at the 41^st Annual J.P. Morgan Healthcare Conference on January 11, 2023, at 5:15 p.m. PST. The event will focus on TransMedics' innovative organ transplant therapies for patients with end-stage organ failures. A live and archived webcast will be available on their website. Established in Andover, Massachusetts, TransMedics leads in portable extracorporeal warm perfusion, aiming to enhance donor organ preservation and viability.

ANDOVER, Mass., Dec. 21, 2022 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the upcoming 41^st Annual J.P. Morgan Healthcare Conference. The presentation will take place on Wednesday, January 11, 2023, at 5:15 p.m. Pacific Standard Time / 8:15 p.m. Eastern Standard Time.

Event: 41^st Annual J.P. Morgan Healthcare Conference
Date: Wednesday, January 11, 2023
Time: 5:15 p.m. PST

A live and archived webcast of the presentation will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. 

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
332-895-3222
Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-participate-in-the-41st-annual-jp-morgan-healthcare-conference-301708384.html

SOURCE TransMedics Group, Inc.

FAQ

When is TransMedics' presentation at the J.P. Morgan Healthcare Conference?

TransMedics will present on January 11, 2023, at 5:15 p.m. PST.

What is the focus of TransMedics' presentation at the conference?

The presentation will highlight their organ transplant therapies for end-stage organ failure.

Where can I watch TransMedics' conference presentation?

A live and archived webcast will be available on the Investors section of TransMedics' website.

What is the significance of the 41st J.P. Morgan Healthcare Conference for TransMedics?

It provides an opportunity to showcase their advancements in organ transplantation technology.

What technology does TransMedics specialize in?

TransMedics specializes in portable extracorporeal warm perfusion for donor organ preservation.